AstraZeneca's Q2 revenue up 31% to $10.8B

Friday, 29. July 2022 08:02

AstraZeneca plc said on Thursday that its revenue in the second quarter of fiscal 2022 amounted to $10.8 billion, soaring 31% compared to the same period last year.

Reported earnings per share (EPS) for the trimester slid 45% year on year to $0.23, while core EPS skyrocketed 92% year on year to $1.72.

"Given the ongoing performance of our underlying business and the contribution of our COVID-19 medicines, we are updating our revenue guidance for 2022. This has enabled us to increase our R&D investment in the exciting number of pipeline opportunities that can benefit patients and drive long term sustainable growth for our company," CEO Pascal Soriot stated.

Related Links: AstraZeneca plc
Baha Breaking News (BBN) / NP